Kristin Chenoweth's “Queen of Versailles” musical gets shut down early after savage reviews Geno Smith's frustration boils over with obscene gesture toward fed-up Raiders fans ...

Arcus halts the late-stage STAR-221 study for futility, dealing a setback to its domvanalimab program with Gilead. Stock down.

While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, ...

Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...

The centre houses an <a href=" Harmony Pro linear accelerator, one of the most advanced radiotherapy systems in the world ...

QBS72S, a LAT1-targeted agent, shows potential in treating leptomeningeal disease, improving survival rates in metastatic ...

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...

Akeso, Inc. (9926.HK) (Akeso or the Company) announced the presentation of a Phase II clinical study that included a ...

Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...

SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading ...

Nancy Frandsen looks back on her career, from answering a paralegal advert to expanding RCCB’s ‘entrepreneurial’ IP practice ...